Metabolic profiling of human blood by high-resolution ion mobility mass spectrometry (IM-MS)

International Journal of Mass Spectrometry

Volumn 298, Issue 1-3, 2010, Pages 78-90

  Dwivedi, Prabha ^a   Schultz, Albert J ^b   Hill Jr, Herbert H ^a  

^a WASHINGTON STATE UNIVERSITY   (United States)

^b Ionwerks   (United States)

Author keywords

Blood metabolite; IM MS; IMS; Isomer separation; Metabolomics; Mobility mass correlation curve (MMCC)

Indexed keywords

EID: 78349308282     PISSN: 13873806     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijms.2010.02.007     Document Type: Article

References (117)

1. David L.N., Michael M.C. Lehninger Principles of Biochemistry 2004, W. H. Freeman. fourth edition.
2. Michal G. Biochemical Pathways: An Atlas of Biochemistry and Molecular Biology 1999, John Wiley & Sons, New York. G. Michal (Ed.).
3. Goodacre R. Metabolomics-the way forward. Metabolomics 2005, 1(1):1-2.
4. Goodacre R., Vaidyanathan S., Dunn W.B., Harrigan G.G., Kell D.B. Metabolomics by numbers: acquiring and understanding global metabolite data. Trends in Biotechnology 2004, 22(5):245-252.
5. Thomas G.H. Metabolomics breaks the silence. Trends in Microbiology 2001, 9(4):158-1158.
6. Horning E.C., Horning M.G. Metabolic profiles: gas-phase methods for analysis of metabolites. Clinical Chemistry 1971, 17(8):802-809.
7. Dunckley T., Coon K.D., Stephan D.A. Discovery and development of biomarkers of neurological disease. Drug Discovery Today 2005, 10(5):326-334.
8. Fell D.A. Beyond genomics. Trends in Genetics 2001, 17(12):680-682.
9. Fernie A.R., Trethewey R.N., Krotzky A.J., Willmitzer L. Innovation-metabolite profiling: from diagnostics to systems biology. Nature Reviews Molecular Cell Biology 2004, 5(9):763-769.
10. Fiehn O. Metabolomics-the link between genotypes and phenotypes. Plant Molecular Biology 2002, 48(1-2):155-171.
11. Kodo N., Millington D.S., Norwood D.L., Roe C.R. Quantitative assay of free and total carnitine using tandem mass spectrometry. Clinica Chimica Acta 1990, 186(3):383-390.
12. Rashed M.S., Bucknall M.P., Little D., Awad A., Jacob M., Alamoudi M., Alwattar M., Ozand P.T. Screening blood spots for inborn errors of metabolism by electrospray tandem mass spectrometry with a microplate batch process and a computer algorithm for automated flagging of abnormal profiles. Clinical Chemistry (Washington, D.C.) 1997, 43(7):1129-1141.
13. Giovannoni G., Heales S.J.R., Silver N.C., O'Riordan J., Miller R.F., Land J.M., Clark J.B., Thompson E.J. Raised serum nitrate and nitrite levels in patients with multiple sclerosis. Journal of the Neurological Sciences 1997, 145(1):77-81.
14. Zangerle R., Fuchs D., Reibnegger G., Werner-Felmayer G., Gallati H., Wachter H., Werner E.R. Serum nitrite plus nitrate in infection with human immunodeficiency virus type-1. Immunobiology 1995, 193(1):59-70.
15. Kawashima H., Inage Y., Ogihara M., Kashiwagi Y., Takekuma K., Hoshika A., Mori T., Watanabe Y. Serum and cerebrospinal fluid nitrite/nitrate levels in patients with rotavirus gastroenteritis induced convulsion. Life Sciences 2004, 74(11):1397-1405.
16. Kawashima H., Watanabe Y., Ichiyama T., Mizuguchi M., Yamada N., Kashiwagi Y., Takekuma K., Hoshika A., Mori T. High concentration of serum nitrite/nitrate obtained from patients with influenza-associated encephalopathy. Pediatrics International 2002, 44(6):705-707.
17. Zarzycki P.K., Kulhanek K.M., Smith R., Clifton V.L. Determination of steroids in human plasma using temperature-dependent inclusion chromatography for metabolomic investigations. Journal of Chromatography A 2006, 1104(1-2):203-208.
18. Figueroa V., Milla C., Parks E.J., Schwarzenberg S.J., Moran A. Abnormal lipid concentrations in cystic fibrosis. American Journal of Clinical Nutrition 2002, 75(6):1005-1011.
19. Caulfield M.P., Lynn T., Gottschalk M.E., Jones K.L., Taylor N.F., Malunowicz E.M., Shackleton C.H.L., Reitz R.E., Fisher D.A. The diagnosis of congenital adrenal hyperplasia in the newborn by gas chromatography/mass spectrometry analysis of random urine specimens. The Journal of Clinical Endocrinology and Metabolism 2002, 87(8):3682-3690.
20. Shackleton C. Biochemical diagnosis of Antley-Bixler syndrome by steroid analysis. American Journal of Medical Genetics Part A 2004, 128A(3):223-231.
21. Gornati R., Bembi B., Tong X., Boscolo R., Bruno B. Total glycolipid and glucosylceramide content in serum and urine of patients with Gaucher's disease type 3 before and after enzyme replacement therapy. Clinica Chimica Acta 1998, 271(2):151-161.
22. Zhang X., Kiechle Frederick L. Review: glycosphingolipids in health and disease. Annals of Clinical and Laboratory Science 2004, 34(1):3-13.
23. Vance D.E., Krivit W., Sweeley C.C. Concentrations of glycosyl ceramides in plasma and red cells in Fabry's disease, a glycolipid lipidosis. Journal of Lipid Research 1969, 10(2):188-192.
24. Tall A.R., Jiang X.C. Detection and Treatment of Atherosclerosis based on Plasma Sphingomyelin Concentration. Application 2001, Trustees of Columbia University in the City of New York, USA, WO, 76 pp.
25. Mirzoyan S.A., Mkheyan E.E., Sekoyan E.S., Grigoryan E.K., Bakunts G.O. Blood glycolipids in patients with brain blood-circulation disorders. Zhurnal Nevropatologii i Psikhiatrii imeni S. S. Korsakova 1978, 78(9):1317-1322.
26. Atzpodien W., Huewels G., Kremer G.J., Schnellbacher E. Study of plasma glycosphingolipids in acute hepatitis. Verhandlungen der Deutschen Gesellschaft fuer Innere Medizin 1976, 82(1):429-431.
27. Markuszewski M.J., Szczykowska M., Siluk D., Kaliszan R. Human red blood cells targeted metabolome analysis of glycolysis cycle metabolites by capillary electrophoresis using an indirect photometric detection method. Journal of Pharmaceutical and Biomedical Analysis 2005, 39(3-4):636-642.
28. Dettmer K., Hammock B.D. Metabolomics-a new exciting field within the "omics" sciences. Environmental Health Perspectives 2004, 112(7):A396-A397.
29. Dunn W.B., Ellis D.I. Metabolomics: current analytical platforms and methodologies. Trends in Analytical Chemistry 2005, 24(4):285-294.
30. Fiehn O. Combining genomics, metabolome analysis, and biochemical modelling to understand metabolic networks. Comparative and Functional Genomics 2001, 2(3):155-168.
31. Jiye A., Trygg J., Gullberg J., Johansson A.I., Jonsson P., Antti H., Marklund S.L., Moritz T. Extraction and GC/MS analysis of the human blood plasma metabolome. Analytical Chemistry 2005, 77(24):8086-8094.
32. Hope J.L., Prazen B.J., Nilsson E.J., Lidstrom M.E., Synovec R.E. Comprehensive two-dimensional gas chromatography with time-of-flight mass spectrometry detection: analysis of amino acid and organic acid trimethylsilyl derivatives, with application to the analysis of metabolites in rye grass samples. Talanta 2005, 65(2):380-388.
33. Katz J.E., Dumlao D.S., Clarke S., Hau J. A new technique (COMSPARI) to facilitate the identification of minor compounds in complex mixtures by GC/MS and LC/MS: tools for the visualization of matched datasets. Journal of the American Society for Mass Spectrometry 2004, 15(4):580-584.
34. Taylor J., King Ross D., Altmann T., Fiehn O. Application of metabolomics to plant genotype discrimination using statistics and machine learning. Bioinformatics (Oxford, England) 2002, 18(Suppl. 2):S241-S248.
35. Gamache P.H., Meyer D.F., Granger M.C., Acworth I.N. Metabolomic applications of electrochemistry/mass spectrometry. Journal of the American Society for Mass Spectrometry 2004, 15(12):1717-1726.
36. Lu W., Kimball E., Rabinowitz J.D. A high-performance liquid chromatography-tandem mass spectrometry method for quantitation of nitrogen-containing intracellular metabolites. Journal of the American Society for Mass Spectrometry 2006, 17(1):37-50.
37. Pham-Tuan H., Kaskavelis L., Daykin Clare A., Janssen H.-G. Method development in high-performance liquid chromatography for high-throughput profiling and metabonomic studies of biofluid samples. Journal of Chromatography B, Analytical Technologies in the Biomedical and Life Sciences 2003, 789(2):283-301.
38. Vigneau-Callahan K.E., Shestopalov A.I., Milbury P.E., Matson W.R., Kristal B.S. Characterization of diet-dependent metabolic serotypes: analytical and biological variability issues in rats. Journal of Nutrition 2001, 131(3):924S-932S.
39. Wagner S., Scholz K., Donegan M., Burton L., Wingate J., Voelkel W. Metabonomics and biomarker discovery: LC-MS metabolic profiling and constant neutral loss scanning combined with multivariate data analysis for mercapturic acid analysis. Analytical Chemistry 2006, 78(4):1296-1305.
40. Wilson Ian D., Plumb R., Granger J., Major H., Williams R., Lenz Eva M. HPLC-MS-based methods for the study of metabonomics. Journal of Chromatography B, Analytical Technologies in the Biomedical and Life Sciences 2005, 817(1):67-76.
41. Yang J., Zhao X., Liu X., Wang C., Gao P., Wang J., Li L., Gu J., Yang S., Xu G. High performance liquid chromatography-mass spectrometry for metabonomics: potential biomarkers for acute deterioration of liver function in chronic hepatitis B. Journal of Proteome Research 2006, 5(3):554-561.
42. Anon. Research profile; CE/MS for quantitative metabolome analysis. Journal of Proteome Research 2003, 2(5):463.
43. Sato S., Soga T., Nishioka T., Tomita M. Simultaneous determination of the main metabolites in rice leaves using capillary electrophoresis mass spectrometry and capillary electrophoresis diode array detection. Plant Journal 2004, 40(1):151-163.
44. Soga T., Ohashi Y., Ueno Y., Naraoka H., Tomita M., Nishioka T. Quantitative metabolome analysis using capillary electrophoresis mass spectrometry. Journal of Proteome Research 2003, 2(5):488-494.
45. Suresh B.C.V., Song E.J., Babar S.M.E., Wi M.H., Yoo Y.S. Capillary electrophoresis at the omics level: towards systems biology. Electrophoresis 2006, 27(1):97-110.
46. Chen X., Kong L., Su X., Pan C., Ye M., Zou H. Integration of ion-exchange chromatography fractionation with reversed-phase liquid chromatography-atmospheric pressure chemical ionization mass spectrometer and matrix-assisted laser desorption/ionization time-of-flight mass spectrometry for isolation and identification of compounds in Psoralea corylifolia. Journal of Chromatography A 2005, 1089(1-2):87-100.
47. 1H NMR-based metabonomic study of urine and plasma samples obtained from healthy human subjects. Journal of Pharmaceutical and Biomedical Analysis 2003, 33(5):1103-1115.
48. Bhalla R., Narasimhan K., Swarup S. Metabolomics and its role in understanding cellular responses in plants. Plant Cell Reports 2005, 24(10):562-571.
49. Nicholls A.W., Holmes E., Lindon J.C., Shockcor J.P., Farrant R.D., Haselden J.N., Damment S.J., Waterfield C.J., Nicholson J.K. Metabonomic investigations into hydrazine toxicity in the rat. Chemical Research in Toxicology 2001, 14(8):975-987.
50. Holmes E., Nicholls A.W., Lindon J.C., Connor S.C., Connelly J.C., Haselden J.N., Damment S.J., Spraul M., Neidig P., Nicholson J.K. Chemometric models for toxicity classification based on NMR spectra of biofluids. Chemical Research in Toxicology 2000, 13(6):471-478.
51. 3 in rats. Journal of Inorganic Biochemistry 2005, 99(11):2151-2160.
52. Viant M.R., Rosenblum E.S., Tieerdema R.S. NMR-based metabolomics: a powerful approach for characterizing the effects of environmental stressors on organism health. Environmental Science & Technology 2003, 37(21):4982-4989.
53. Pendyala G., Want E.J., Webb W., Siuzdak G., Fox H.S. Biomarkers for neuroAIDS: the widening scope of metabolomics. Journal of Neuroimmune Pharmacology 2007, 2(1):72-80.
54. Dunn W.B. Current trends and future requirements for the mass spectrometric investigation of microbial, mammalian and plant metabolomes. Physical Biology 2008, 5(1):11001.
55. 13C isotopic analysis in life science research. Mass Spectrometry Reviews 2007, 26(6):751-774.
56. Metz T.O., Zhang Q., Page J.S., Shen Y., Callister S.J., Jacobs J.M., Smith R.D. The future of liquid chromatography-mass spectrometry (LC-MS) in metabolic profiling and metabolomic studies for biomarker discovery. Biomarkers in Medicine 2007, 1(1):159-185.
57. Witkamp R.F. Genomics and systems biology-how relevant are the developments to veterinary pharmacology, toxicology and therapeutics?. Journal of Veterinary Pharmacology and Therapeutics 2005, 28(3):235-245.
58. Ad de Jong G.J. Foreword: new developments in CE, CIEF and CE for metabolomics. Journal of Chromatography A 2008, 1204(2):129.
59. Barbas C., Vallejo M., Garcia A., Barlow D., Hanna-Brown M. Capillary electrophoresis as a metabolomic tool in antioxidant therapy studies. Journal of Pharmaceutical and Biomedical Analysis 2008, 47(2):388-398.
60. Monton M.R., Soga T. Metabolome analysis by capillary electrophoresis-mass spectrometry. Journal of Chromatography A 2007, 1168(1-2):237-246. (discussion 236).
61. Ramautar R., Somsen G.W., de Jong G.J. CE-MS in metabolomics. Electrophoresis 2009, 30(1):276-291.
62. Soga T. Capillary electrophoresis-mass spectrometry for metabolomics. Methods in Molecular Biology 2007, 358:129-137.
63. van der Kooy F., Maltese F., Choi Y.H., Kim H.K., Verpoorte R. Quality control of herbal material and phytopharmaceuticals with MS and NMR based metabolic fingerprinting. Planta Medica 2009, 75(7):763-775.
64. Queiroz E.F., Wolfender J.L., Hostettmann K. Modern approaches in the search for new lead antiparasitic compounds from higher plants. Current Drug Targets 2009, 10(3):202-211.
65. Powers R. NMR metabolomics and drug discovery. Magnetic Resonance in Chemistry 2009, 47(S1):S2-S11.
66. Vangala S., Tonelli A. Biomarkers, metabonomics, and drug development: can inborn errors of metabolism help in understanding drug toxicity?. The AAPS Journal 2007, 9(3):E284-E297.
67. Orhan H. Analyses of representative biomarkers of exposure and effect by chromatographic, mass spectrometric, and nuclear magnetic resonance techniques: method development and application in life sciences. Journal of Separation Science 2007, 30(2):149-174.
68. Sem D.S., Pellecchia M. NMR in the acceleration of drug discovery. Current Opinion in Drug Discovery & Development 2001, 4(4):479-492.
69. DeAngelis C.D., Zerhouni E.A., Director Elias N.I.H., Zerhouni A. MD, reflects on agency's challenges, priorities. Journal of the American Medical Association 2003, 289(12):1492-1493.
70. Zerhouni E. The NIH roadmap. Science 2003, 302(5642).
71. Valentine S.J., Plasencia M.D., Liu X.Y., Krishnan M., Naylor S., Udseth H.R., Smith R.D., Clemmer D.E. Toward plasma proteome profiling with ion mobility-mass spectrometry. Journal of Proteome Research 2006, 5(11):2977-2984.
72. Fenn L.S., Kliman M., Mahsut A., Zhao S.R., McLean J.A. Characterizing ion mobility-mass spectrometry conformation space for the analysis of complex biological samples. Analytical and Bioanalytical Chemistry 2009, 394(1):235-244.
73. Kanu A.B., Dwivedi P., Tam M., Matz L., Hill H.H. Ion mobility-mass spectrometry. Journal of Mass Spectrometry 2008, 43(1):1-22.
74. Hyung S.J., Robinson C.V., Ruotolo B.T. Gas-phase unfolding and disassembly reveals stability differences in ligand-bound multiprotein complexes. Chemistry & Biology 2009, 16(4):382-390.
75. Chan E.C., New L.S., Yap C.W., Goh L.T. Pharmaceutical metabolite profiling using quadrupole/ion mobility spectrometry/time-of-flight mass spectrometry. Rapid Communications in Mass Spectrometry 2009, 23(3):384-394.
76. Mie A., Ray A., Axelsson B.O., Jornten-Karlsson M., Reimann C.T. Terbutaline enantiomer separation and quantification by complexation and field asymmetric ion mobility spectrometry-tandem mass spectrometry. Analytical Chemistry 2008, 80(11):4133-4140.
77. Dwivedi P., Hill H.H. A rapid analytical method for hair analysis using ambient pressure ion mobility mass spectrometry with electrospray ionization (ESI-IMMS). International Journal for Ion Mobility Spectrometry 2008, 11(1-4):61-69.
78. Eiceman G.A., Blyth D.A., Shoff D.B., Snyder A.P. Screening of solid commercial pharmaceuticals using ion mobility spectrometry. Analytical Chemistry 1990, 62(14):1374-1379.
79. Borsdorf H., Nazarov E.G., Eiceman G.A. Atmospheric pressure chemical ionization studies of non-polar isomeric hydrocarbons using ion mobility spectrometry and mass spectrometry with different ionization techniques. Journal of American Society for Mass Spectrometry 2002, 13(9):1078-1087.
80. Zhao Y.Y., Liu X., Boyd J.M., Qin F., Li J., Li X.F. Identification of N-nitrosamines in treated drinking water using nanoelectrospray ionization high-field asymmetric waveform ion mobility spectrometry with quadrupole time-of-flight mass spectrometry. Journal of Chromatographic Science 2009, 47(1):92-96.
81. Clowers B.H., Steiner W.E., Dion H.M., Matz L.M., Tam M., Tarver E.E., Hill H.H. Evaluation of sulfonylurea herbicides using high resolution electrospray ionization ion mobility quadrupole mass spectrometry. Field Analytical Chemistry and Technology 2001, 5(6):302-312.
82. Mie A., Sandulescu M., Mathiasson L., Emneus J., Reimann Curt T. Analysis of triazines and associated metabolites with electrospray ionization field-asymmetric ion mobility spectrometry/mass spectrometry. Analytical Sciences: The International Journal of the Japan Society for Analytical Chemistry 2008, 24(8):973-978.
83. Steiner W.E., Klopsch S.J., English W.A., Clowers B.H., Hill H.H. Detection of a chemical warfare agent simulant in various aerosol matrixes by ion mobility time-of-flight mass spectrometry. Analytical Chemistry 2005, 77(15):4792-4799.
84. Hill, H.H. Jr., Dwivedi, P., Kanu, A.B., Reduction in false positive responses for explosives detection using ion mobility-mass spectrometry (IMMS). First Indo-US Workshop on Spectroscopy, vol. 14, Laser and Spectroscopy Society of India, B.H.U. Varanasi, India, 2006, pp. 92-103.
85. Waltman M.J., Dwivedi P., Hill H.H., Blanchard W.C., Ewing R.G. Characterization of a distributed plasma ionization source (DPIS) for ion mobility spectrometry and mass spectrometry. Talanta 2008, 77(1):249-255.
86. Dwivedi P., Wu P., Klopsch S., Puzon G., Xun L., Hill H. Metabolic profiling by ion mobility mass spectrometry (IMMS). Metabolomics 2007, (Published online: 11 December 2007).
87. Asbury G.R., Hill H.H. Evaluation of ultrahigh resolution ion mobility spectrometry as an analytical separation device in chromatographic terms. Journal of Microcolumn Separations 2000, 12(3):172-178.
88. Wu C., Siems W.F., Asbury G.R., Hill H.H. Electrospray ionization high-resolution ion mobility spectrometry-mass spectrometry. Analytical Chemistry 1998, 70(23):10.
89. Steiner W.E., Clowers B.H., Fuhrer K., Gonin M., Matz L.M., Siems W.F., Schultz A.J., Hill H.H. Electrospray ionization with ambient pressure ion mobility separation and mass analysis by orthogonal time-of-flight mass spectrometry. Rapid Communications in Mass Spectrometry 2001, 15(23):2221-2226.
90. Revercomb H.E., Mason E.A. Theory of plasma chromatography/gaseous electrophoresis-a review. Analytical Chemistry 1975, 47(7):970.
91. Sud M., Fahy E., Cotter D., Brown A., Dennis E.A., Glass C.K., Merrill A.H., Murphy R.C., Raetz C.R., Russell D.W., Subramaniam S. LMSD: LIPID MAPS structure database. Nucleic Acids Research 2007, 35(Database issue):D527-D532.
92. Fahy E., Subramaniam S., Brown H.A., Glass C.K., Merrill A.H., Murphy R.C., Raetz C.R.H., Russell D.W., Seyama Y., Shaw W., Shimizu T., Spener F., van Meer G., VanNieuwenhze M.S., White S.H., Witztum J.L., Dennis E.A. A comprehensive classification system for lipids. Journal of Lipid Research 2005, 46(5):839-862.
93. Smith C.A., O'Maille G., Want E.J., Qin C., Trauger S.A., Brandon T.R., Custodio D.E., Abagyan R., Siuzdak G. METLIN-a metabolite mass spectral database. Therapeutic Drug Monitoring 2005, 27(6):747-751.
94. Kopka J., Schauer N., Krueger S., Birkemeyer C., Usadel B., Bergmuller E., Dormann P., Weckwerth W., Gibon Y., Stitt M., Willmitzer L., Fernie A.R., Steinhauser D. GMD@CSB.DB: the Golm Metabolome Database. Bioinformatics 2005, 21(8):1635-1638.
95. Koeniger S.L., Merenbloom S.I., Valentine S.J., Jarrold M.F., Udseth H.R., Smith R.D., Clemmer D.E. An IMS-IMS analogue of MS-MS. Analytical Chemistry 2006, 78(12):4161-4174.
96. Merenbloom S.I., Koeniger S.L., Valentine S.J., Plasencia M.D., Clemmer D.E. IMS-IMS and IMS-IMS-IMS/MS for separating peptide and protein fragment ions. Analytical Chemistry 2006, 78(8):2802-2809.
97. Valentine S.J., Kurulugama R.T., Bohrer B.C., Merenbloom S.I., Sowell R.A., Mechref Y., Clemmer D.E. Developing IMS-IMS-MS for rapid characterization of abundant proteins in human plasma. International Journal of Mass Spectrometry 2009, 283(1-3):149-160.
98. Woods A.S., Ugarov M., Egan T., Koomen J., Gillig K.J., Fuhrer K., Gonin M., Schultz J.A. Lipid/peptide/nucleotide separation with MALDI-ion mobility-TOF MS. Analytical Chemistry 2004, 76(8):2187-2195.
99. Clowers B.H., Dwivedi P., Steiner W.E., Hill H.H., Bendiak B. Separation of sodiated isobaric disaccharides and trisaccharides using electrospray ionization-atmospheric pressure ion mobility-time of flight mass spectrometry. Journal of American Society of Mass Spectrometry 2005, 16(5):660-669.
100. Dwivedi P., Bendiak B., Clowers B.H., Hill H.H. Rapid resolution of carbohydrate isomers by electrospray ionization ambient pressure ion mobility spectrometry-time-of-flight mass spectrometry (ESI-APIMS-TOFMS). Journal of the American Society for Mass Spectrometry 2007, 18(7):1163-1175.
101. Britz-McKibbin P., Terabe S. On-line preconcentration strategies for trace analysis of metabolites by capillary electrophoresis. Journal of Chromatography A 2003, 1000(1-2):917-934.
102. Lidebjer C., Leanderson P., Ernerudh J., Jonasson L. Low plasma levels of oxygenated carotenoids in patients with coronary artery disease. Nutrition, Metabolism, and Cardiovascular Diseases 2007, 17(6):448-456.
103. Kita Y., Takahashi T., Uozumi N., Nallan L., Gelb M.H., Shimizu T. Pathway-oriented profiling of lipid mediators in macrophages. Biochemical and Biophysical Research Communications 2005, 330(3):898-906.
104. Serhan C.N. Mediator lipidomics. Prostaglandins & Other Lipid Mediators 2005, 77(1-4):4-14.
105. Jackson S.N., Wang H.Y.J., Woods A.S. Direct tissue analysis of phospholipids in rat brain using MALDI-TOFMS and MALDI-ion mobility-TOFMS. Journal of the American Society for Mass Spectrometry 2005, 16(2):133-138.
106. Ruotolo B.T., Gillig K.J., Stone E.G., Russell D.H. Peak capacity of ion mobility mass spectrometry: separation of peptides in helium buffer gas. Journal of Chromatography B Analytical Technologies in Biomedical and Life Sciences 2002, 782(1-2):385-392.
107. Ruotolo B.T., Verbeck G.F., Thomson L.M., Woods A.S., Gillig K.J., Russell D.H. Distinguishing between phosphorylated and nonphosphorylated peptides with ion mobility-mass spectrometry. Journal of Proteome Research 2002, 1(4):303-306.
108. Morris M., Watkins S.M. Focused metabolomic profiling in the drug development process: advances from lipid profiling. Current Opinion in Chemical Biology 2005, 9(4):407-412.
109. Ruotolo B.T., Gillig K.J., Stone E.G., Russell D.H. Peak capacity of ion mobility mass spectrometry: separation of peptides in helium buffer gas. Journal of Chromatography B, Analytical Technologies in the Biomedical and Life Sciences 2003, 782(1):8.
110. Frahm J.L., Howard B.E., Heber S., Muddiman D.C. Accessible proteomics space and its implications for peak capacity for zero-, one- and two-dimensional separations coupled with FT-ICR and TOF mass spectrometry. Journal of Mass Spectrometry 2006, 41(3):281-288.
111. Rose D.J., Opiteck G.J. Two-dimensional gel electrophoresis/liquid chromatography for the micropreparative isolation of proteins. Analytical Chemistry 1994, 66(15):2529-2536.
112. McLean J.A., Ruotolo B.T., Gillig K.J., Russell D.H. Ion mobility-mass spectrometry: a new paradigm for proteomics. International Journal of Mass Spectrometry 2005, 240(3):301-315.
113. Liu X.Y., Valentine S.J., Plasencia M.D., Trimpin S., Naylor S., Clemmer D.E. Mapping the human plasma proteome by SCX-LC-IMS-MS. Journal of the American Society for Mass Spectrometry 2007, 18(7):1249-1264.
114. Merenbloom S.I., Bohrer B.C., Koeniger S.L., Clemmer D.E. Assessing the peak capacity of IMS-IMS separations of tryptic peptide ions in He at 300K. Analytical Chemistry 2007, 79(2):515-522.
115. Want E.J., O'Maille G., Smith C.A., Brandon T.R., Uritboonthai W., Qin C., Trauger S.A., Siuzdak G. Solvent-dependent metabolite distribution. Clustering, and protein extraction for serum profiling with mass spectrometry. Analytical Chemistry 2006, 78(3):743-752.
116. Roy S.M., Anderle M., Lin H., Becker C.H. Differential expression profiling of serum proteins and metabolites for biomarker discovery. International Journal of Mass Spectrometry 2004, 238(2):163-171.
117. Nordstrom A., O'Maille G., Qin C., Siuzdak G. Nonlinear data alignment for UPLC-MS and HPLC-MS based metabolomics: quantitative analysis of endogenous and exogenous metabolites in human serum. Analytical Chemistry 2006, 78(10):3289-3295.